At a glance
- Originator Kotobuki Seiyaku
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia; Type 2 diabetes mellitus
Most Recent Events
- 22 Aug 2003 No development reported - Preclinical for Hyperlipidaemia in Japan (unspecified route)
- 22 Aug 2003 No development reported - Preclinical for Type-2 diabetes mellitus in Japan (unspecified route)
- 18 Sep 2001 Preclinical development for Hyperlipidaemia in Japan (Unknown route)